榴莲视频

This Special Communication discusses the essential elements of designing and implementing informed consent practices for psychedelic medicine.

This Viewpoint evaluates Texas鈥� proposals to define the scope of the life exception for the state鈥檚 abortion ban and argues that these approaches do not allow physicians to follow the national standards of care, avoid criminal liability, or have sufficient notice of what the law permits.

This Viewpoint explains how exceptions can be used to connect patients via telehealth with a physician in another state, why this is a more practical and effective strategy, and what needs to happen for this to be a feasible solution.

This Viewpoint discusses why the legality of calling patients located in another state has suddenly been called into question.

This Viewpoint lists the top 3 pediatric drugs and product shortages, considers the federal government鈥檚 and manufacturers鈥� ethical duty to protect children, reviews the causes for the shortages, and suggests policy changes that could help fill in the gap.

This Viewpoint discusses the legal risks physicians and health care facilities may incur by miscoding a surgical or chemical abortion as a miscarriage to conceal an abortion procedure.

This Viewpoint discusses how some pulse oximeters can provide incorrect oxygen saturation data for dark-skinned patients compared with light-skinned patients, describes the reasons that biased oximeters remained in use, and highlights why a rule recently proposed by the US Department of Health and Human Services may bring about needed change in the use of pulse oximetry for patients with dark skin.

This Viewpoint discusses a proposed DHHS rule to address discrimination in clinical algorithms and the need for additional considerations to ensure the burden of liability for biased algorithms is not disproportionately placed on health care professionals.

This Viewpoint examines the murky legal treatment of various health-related wearable or other general wellness products for patients, physicians, and manufacturers, and recommends solutions.

Viewpoint describes the limitations of patient privacy under HIPPA regarding abortion services and miscarriages and discusses important considerations for patients, clinicians, and health care centers.

This Viewpoint discusses the definitions of medical devices and low-risk general wellness products and examines the difficulties the difference between these types of products pose for regulation, consumer understanding, physician use and interpretation, privacy, reimbursement, and equity.

This Viewpoint advocates for the US federal government to take advantage of COVID-19 pandemic-inspired momentum to promote telehealth via regulatory leadership.

This Viewpoint describes changes in reimbursement standards, patient privacy (HIPAA) regulations, and licensing requirements that have occurred around provision of telehealth in the US in response to the COVID-19 pandemic and highlights opportunities to further standardize regulations and facilitate use of telehealth after the pandemic.